GNOCCHI, DAVIDE

GNOCCHI, DAVIDE  

Mostra prodotti
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
3,5,3 '-Triiodothyronine (T-3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes 2012 Gnocchi, Davide; Leoni, Silvia; Sandra, Incerpi; Bruscalupi, Giovannella
Circadian rhythms and hormonal homeostasis: Pathophysiological implications 2017 Gnocchi, Davide; Bruscalupi, Giovannella
Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity 2020 Gnocchi, D.; Ellis, E. C. S.; Johansson, H.; Eriksson, M.; Bruscalupi, G.; Steffensen, K. R.; Parini, P.
Effect of fructose and 3,5-diiodothyronine on lipid accumulation and insulin signalling in NAFLD-like hepatocytes 2014 Gnocchi, Davide; M., Massimi; A., Alisi; S., Incerpi; Bruscalupi, Giovannella
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells 2024 Moliterni, Camilla; Vari, Francesco; Schifano, Emily; Tacconi, Stefano; Stanca, Eleonora; Friuli, Marzia; Longo, Serena; Conte, Maria; Salvioli, Stefano; Gnocchi, Davide; Mazzocca, Antonio; Uccelletti, Daniela; Vergara, Daniele; Dini, Luciana; Giudetti, Anna Maria
Oleic acid but not fructose induces steatosis and insulin resistance in primary adult and fetal hepatocytes. 3,5-T2 prevents and reverts these effects differently in adult and fetal cells. 2011 Gnocchi, Davide; Leoni, Silvia; Bruscalupi, Giovannella
Primary Hepatocytes as a model to investigate non-alchoolic fatty liver disease (NAFLD): potential therapeutic effects of Diiodothyronines 2013 Gnocchi, Davide